PeptideScanner retained ClinicalTrials.gov record NCT06677502 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-12-31, and PeptideScanner's reviewed identity mapping was cerebrolysin. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1